HEADER IMMUNE SYSTEM 25-JUN-01 1JGD TITLE HLA-B*2709 BOUND TO DECA-PEPTIDE S10R COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN LYMPHOCYTE ANTIGEN HLA-B27; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: PEPTIDE S10R; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-B OR HLAB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), HLA (HUMAN LEUKOCYTE KEYWDS 2 ANTIGEN), IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.C.HILLIG,M.HUELSMEYER,W.SAENGER,A.VOLZ,B.UCHANSKA-ZIEGLER,A.ZIEGLER REVDAT 7 16-AUG-23 1JGD 1 REMARK SEQADV REVDAT 6 24-JAN-18 1JGD 1 JRNL REVDAT 5 13-JUL-11 1JGD 1 VERSN REVDAT 4 24-FEB-09 1JGD 1 VERSN REVDAT 3 13-JAN-04 1JGD 1 JRNL REMARK MASTER REVDAT 2 29-JUL-03 1JGD 1 JRNL REVDAT 1 01-JUL-03 1JGD 0 JRNL AUTH R.C.HILLIG,M.HUELSMEYER,W.SAENGER,K.WELFLE,R.MISSELWITZ, JRNL AUTH 2 H.WELFLE,C.KOZERSKI,A.VOLZ,B.UCHANSKA-ZIEGLER,A.ZIEGLER JRNL TITL THERMODYNAMIC AND STRUCTURAL ANALYSIS OF PEPTIDE- AND JRNL TITL 2 ALLELE-DEPENDENT PROPERTIES OF TWO HLA-B27 SUBTYPES JRNL TITL 3 EXHIBITING DIFFERENTIAL DISEASE ASSOCIATION JRNL REF J.BIOL.CHEM. V. 279 652 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14555655 JRNL DOI 10.1074/JBC.M307457200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.HULSMEYER,R.C.HILLIG,A.VOLZ,M.RUHL,W.SCHRODER,W.SAENGER, REMARK 1 AUTH 2 A.ZIEGLER,B.UCHANSKA-ZIEGLER REMARK 1 TITL HLA-B27 SUBTYPES DIFFERENTIALLY ASSOCIATED WITH DISEASE REMARK 1 TITL 2 EXHIBIT SUBTLE STRUCTURAL ALTERATIONS REMARK 1 REF J.BIOL.CHEM. V. 277 47844 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M206392200 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.DEL PORTO,M.D'AMATO,M.T.FIORILLO,L.TUOSTO,E.PICCOLELLA, REMARK 1 AUTH 2 R.SORRENTION REMARK 1 TITL IDENTIFICATION OF A NOVEL HLA-B27 SUBTYPE BY RESTRICTION REMARK 1 TITL 2 ANALYSIS OF A CYTOTOXIC GAMMA DELTA T CELL CLONE REMARK 1 REF J.IMMUNOL. V. 153 3093 1994 REMARK 1 REFN ISSN 0022-1767 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.R.MADDEN,J.C.GORGA,J.L.STROMINGER,D.C.WILEY REMARK 1 TITL THE STRUCTURE OF HLA-B27 REVEALS NONAMER SELF-PEPTIDES BOUND REMARK 1 TITL 2 IN AN EXTENDED CONFORMATION REMARK 1 REF NATURE V. 353 321 1991 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/353321A0 REMARK 1 REFERENCE 4 REMARK 1 AUTH D.R.MADDEN,J.C.GORGA,J.L.STROMINGER,D.C.WILEY REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 A REMARK 1 TITL 2 RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE REMARK 1 TITL 3 BINDING TO MHC REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 70 1035 1992 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/0092-8674(92)90252-8 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 37162 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1905 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 452 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.44000 REMARK 3 B22 (A**2) : 0.82000 REMARK 3 B33 (A**2) : 0.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.45000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.017 ; 0.021 REMARK 3 ANGLE DISTANCE (A) : 1.872 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.984 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.629 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.862 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.618 ; 4.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JGD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-01. REMARK 100 THE DEPOSITION ID IS D_1000013738. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-AUG-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0500 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37162 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 14.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.38600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JGE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, TRIS-HCL, NACL; GLYCEROL AS REMARK 280 CRYO PROTECTANT, PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 64.92200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.21900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 64.92200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.21900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HETEROTRIMERIC COMPLEX REMARK 300 CONSISTING OF ONE HLA-B*2709 (HEAVY) CHAIN, ONE BETA-2- REMARK 300 MICROGLOBULIN (LIGHT) CHAIN AND ONE DECAMERIC MODEL PEPTIDE S10R. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 119 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 227 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP B 76 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG C 1 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 15 -89.83 -24.92 REMARK 500 ARG A 17 30.24 -151.48 REMARK 500 ARG A 17 30.24 -143.06 REMARK 500 ASP A 29 -127.45 49.44 REMARK 500 ALA A 41 -73.46 -39.38 REMARK 500 PRO A 43 130.34 -39.47 REMARK 500 HIS A 114 109.82 -165.38 REMARK 500 SER A 131 -1.82 -142.15 REMARK 500 ARG A 239 -4.75 82.09 REMARK 500 LYS B 48 57.76 -94.80 REMARK 500 TRP B 60 -8.10 79.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HLA-B*2705 IN COMPLEX WITH AN ENDOGENOUS MIXTURE OF NONAMERIC REMARK 900 PEPTIDES REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 IN COMPLEX WITH NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 IN COMPLEX WITH NONA-PEPTIDE M9 DBREF 1JGD A 1 276 UNP P03989 1B27_HUMAN 25 300 DBREF 1JGD B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 1JGD C 1 10 PDB 1JGD 1JGD 1 10 SEQADV 1JGD MET B 0 UNP P61769 CLONING ARTIFACT SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE HIS THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE THR VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR LEU PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER PRO ARG GLU GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG GLU THR GLN SEQRES 6 A 276 ILE CYS LYS ALA LYS ALA GLN THR ASP ARG GLU ASP LEU SEQRES 7 A 276 ARG THR LEU LEU ARG TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR LEU GLN ASN MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 PRO ASP GLY ARG LEU LEU ARG GLY TYR HIS GLN HIS ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 276 SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE THR SEQRES 12 A 276 GLN ARG LYS TRP GLU ALA ALA ARG VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY GLU CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG ALA SEQRES 15 A 276 ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 10 ARG ARG LEU LEU ARG GLY HIS ASN GLN TYR HET GOL A 500 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *452(H2 O) HELIX 1 1 ARG A 14 GLY A 18 5 5 HELIX 2 2 ALA A 49 GLN A 54 1 6 HELIX 3 3 GLY A 56 TYR A 85 1 30 HELIX 4 4 ASP A 137 ALA A 150 1 14 HELIX 5 5 ARG A 151 GLY A 162 1 12 HELIX 6 6 GLY A 162 GLY A 175 1 14 HELIX 7 7 GLY A 175 GLN A 180 1 6 HELIX 8 8 THR A 225 THR A 228 5 4 HELIX 9 9 GLU A 253 GLN A 255 5 3 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N THR A 24 O PHE A 36 SHEET 4 A 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 N LEU A 95 O SER A 11 SHEET 6 A 8 LEU A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 A 8 TRP A 133 ALA A 135 -1 N THR A 134 O ALA A 125 SHEET 1 B 4 LYS A 186 PRO A 193 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 B 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 PRO A 193 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 4 GLU A 222 ASP A 223 0 SHEET 2 D 4 THR A 214 ARG A 219 -1 N ARG A 219 O GLU A 222 SHEET 3 D 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 D 4 LEU A 270 LEU A 272 -1 N LEU A 270 O VAL A 261 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 E 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 F 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 LYS B 94 -1 N LYS B 91 O VAL B 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.14 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.01 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.02 CISPEP 1 TYR A 209 PRO A 210 0 2.42 CISPEP 2 HIS B 31 PRO B 32 0 2.24 SITE 1 AC1 7 THR A 31 THR A 178 LEU A 179 ARG A 181 SITE 2 AC1 7 ASP A 183 TYR A 209 HOH A 638 CRYST1 129.844 48.438 88.532 90.00 121.29 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007702 0.000000 0.004681 0.00000 SCALE2 0.000000 0.020645 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013218 0.00000